Edoxaban filmcoated tablets 15mg, 30 mg & 60 mg

Products

Information

Edoxaban is indicated in prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack (TIA). Edoxaban is indicated in treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the prevention of recurrent DVT and PE in adults for haemodynamically unstable PE patients).
All categories
Finished Dosage FormsTabletsProducts
Main Categories
Finished Dosage Forms
A.forall22D124A.forall is a pharmaceutical group of generic and pharmacy sales companies, focusing on the development, manufacturing and distribution of pharmaceutical products. Alter Pharma uses robust and reliable third-party manufacturers, all with valid GMP accreditations from competent authorities in EU and/or the US. We out-license high-quality products developed internally or through collaborative agreements with other product developers. We provide competitive prices and we work in strict accordance with cGMP. We ensure all products are launched on time. Our business model consists of licensing, registration support and long term supply. At A.forall, we're strongly committed to supporting niche products, geographically specific and markets under development, to achieve the highest standards in this segment.

Join the event!